Company
Profound Medical Corp. (PROF)
Standardized SEC financial data for Profound Medical Corp. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001628808 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Gross margin
70.8%
Operating margin
-256.3%
Net margin
-264.4%
Revenue growth (YoY)
50.7%
Return on equity
-64.1%
ROIC
-290.7%
Free cash flow
-$38.4M
Debt / equity
0.07×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $7.3M | $6.9M | $6.7M | $7.2M | $10.7M | $16.1M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $46.5M | $26.2M | $54.9M | $59.7M |
| Inventory |
Cash flow
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$22.6M | -$23.5M | -$38.2M |
| Capital expenditures | — | — | $176K |
| Free cash flow | — | — |
Get PROF data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PROF/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PROF/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"